OBJECTIVE: While tomato product supplementation, containing antioxidant carotenoids, including lycopene, decreases oxidative stress, the role of purified lycopene as an antioxidant remains unclear. Thus, we tested the effects of different doses of purified lycopene supplementation on biomarkers of oxidative stress in healthy volunteers. METHODS: This was a double-blind, randomized, placebo-controlled trial, examining the effects of 8-week supplementation of purified lycopene, on plasma lycopene levels, biomarkers of lipid peroxidation {LDL oxidizability, malondialdehyde & hydroxynonenals (MDA & HNE), urinary F(2)-isoprostanes}, and markers of DNA damage in urine and lymphocytes. Healthy adults (n = 77, age > or = 40 years), consumed a lycopene-restricted diet for 2 weeks, and were then randomized to receive 0, 6.5, 15, or 30 mg lycopene/day for 8 weeks, while on the lycopene-restricted diet. Blood and urine samples were collected at the beginning and end of Week 2 of lycopene-restricted diet, and at end of Week 10 of the study. RESULTS: Independent of the dose, plasma lycopene levels significantly increased in all lycopene supplemented groups versus placebo (p < 0.05). ANOVA revealed a significant decrease in DNA damage by the comet assay (p = 0.007), and a significant decrease in urinary 8-hydroxy deoxoguanosine (8-OHdG) at 8 weeks versus baseline (p = 0.0002), with 30 mg lycopene/day. No significant inter- or intra-group differences were noted for glucose, lipid profile, or other biomarkers of lipid peroxidation at any dose/time point. CONCLUSIONS: Thus, purified lycopene was bioavailable and was shown to decrease DNA oxidative damage and urinary 8-OHdG at the high dose.
RCT Entities:
OBJECTIVE: While tomato product supplementation, containing antioxidant carotenoids, including lycopene, decreases oxidative stress, the role of purified lycopene as an antioxidant remains unclear. Thus, we tested the effects of different doses of purified lycopene supplementation on biomarkers of oxidative stress in healthy volunteers. METHODS: This was a double-blind, randomized, placebo-controlled trial, examining the effects of 8-week supplementation of purified lycopene, on plasma lycopene levels, biomarkers of lipid peroxidation {LDL oxidizability, malondialdehyde & hydroxynonenals (MDA & HNE), urinary F(2)-isoprostanes}, and markers of DNA damage in urine and lymphocytes. Healthy adults (n = 77, age > or = 40 years), consumed a lycopene-restricted diet for 2 weeks, and were then randomized to receive 0, 6.5, 15, or 30 mg lycopene/day for 8 weeks, while on the lycopene-restricted diet. Blood and urine samples were collected at the beginning and end of Week 2 of lycopene-restricted diet, and at end of Week 10 of the study. RESULTS: Independent of the dose, plasma lycopene levels significantly increased in all lycopene supplemented groups versus placebo (p < 0.05). ANOVA revealed a significant decrease in DNA damage by the comet assay (p = 0.007), and a significant decrease in urinary 8-hydroxy deoxoguanosine (8-OHdG) at 8 weeks versus baseline (p = 0.0002), with 30 mg lycopene/day. No significant inter- or intra-group differences were noted for glucose, lipid profile, or other biomarkers of lipid peroxidation at any dose/time point. CONCLUSIONS: Thus, purified lycopene was bioavailable and was shown to decrease DNA oxidative damage and urinary 8-OHdG at the high dose.
Authors: Veda Diwadkar-Navsariwala; Janet A Novotny; David M Gustin; Jeffery A Sosman; Keith A Rodvold; James A Crowell; Maria Stacewicz-Sapuntzakis; Phyllis E Bowen Journal: J Lipid Res Date: 2003-07-16 Impact factor: 5.922
Authors: Phyllis Bowen; Longwen Chen; Maria Stacewicz-Sapuntzakis; Claudine Duncan; Roohollah Sharifi; Luna Ghosh; Hyung-Sook Kim; Konstantin Christov-Tzelkov; Richard van Breemen Journal: Exp Biol Med (Maywood) Date: 2002-11
Authors: Xianfeng Zhao; Giancarlo Aldini; Elizabeth J Johnson; Helen Rasmussen; Klaus Kraemer; Herb Woolf; Nina Musaeus; Norman I Krinsky; Robert M Russell; Kyung-Jin Yeum Journal: Am J Clin Nutr Date: 2006-01 Impact factor: 7.045
Authors: Ute C Obermüller-Jevic; Estibaliz Olano-Martin; Ana M Corbacho; Jason P Eiserich; Albert van der Vliet; Giuseppe Valacchi; Carroll E Cross; Lester Packer Journal: J Nutr Date: 2003-11 Impact factor: 4.798
Authors: Rebecca E Graff; Andreas Pettersson; Rosina T Lis; Thomas U Ahearn; Sarah C Markt; Kathryn M Wilson; Jennifer R Rider; Michelangelo Fiorentino; Stephen Finn; Stacey A Kenfield; Massimo Loda; Edward L Giovannucci; Bernard Rosner; Lorelei A Mucci Journal: Am J Clin Nutr Date: 2016-01-27 Impact factor: 7.045